SBI Securities’s Damora Therapeutics, Inc. Ordinary Shares DMRA Stock Holding History

SBI Securities’s Portfolio DMRA Stock Details DMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$364	Hold	14	–	–	﹤0.01%	3147
2026 Q1	$363	Hold	14	–	–	﹤0.01%	3008
2025 Q4	$322	Sell	14 -4	-22%	-$70	﹤0.01%	3040
2025 Q3	$67	Hold	18	–	–	﹤0.01%	3630
2025 Q2	$61	Hold	18	–	–	﹤0.01%	3676
2025 Q1	$56	Hold	18	–	–	﹤0.01%	3615
2024 Q4	$84	Buy	+18	New	+$118	﹤0.01%	3507

Other funds holding DMRA

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

SBI Securities's DMRA Position: Q2 2026 in Review

SBI Securities held its Damora Therapeutics, Inc. Ordinary Shares (DMRA) position steady in Q2 2026 at 14 shares worth $364. The position accounts for ﹤0.01% of the portfolio, ranked #3147.

SBI Securities first reported a position in DMRA in Q4 2024 and has held it in 7 quarters since. 2 funds tracked by Wall St. Rank hold DMRA as of Q2 2026.

SBI Securities held 14 shares of Damora Therapeutics, Inc. Ordinary Shares worth $364 as of Q2 2026.
SBI Securities left its Damora Therapeutics, Inc. Ordinary Shares share count unchanged in Q2 2026.
Damora Therapeutics, Inc. Ordinary Shares made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3147 holding.
SBI Securities first reported a position in Damora Therapeutics, Inc. Ordinary Shares in Q4 2024 and has held it in 7 quarters since.
2 funds tracked by Wall St. Rank held Damora Therapeutics, Inc. Ordinary Shares as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.